<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>J Compr Ped</JournalTitle>
            <Issn>2251-8177</Issn>
            <Volume>9</Volume>
            <Issue>3</Issue>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubDate>
            <journal_id_doi>10.5812/compreped.59701</journal_id_doi>
        </Journal>
        <title locale="en_US">Anthracycline-Induced Cardiothoxicity in Children Cancer Patients: An Imaging Study by Two-Dimensional Global Longitudinal Strain Using Automated Function Imaging Technique</title>
        <AuthorList>
            <Author>
                <FirstName>Mohammad Reza</FirstName>
                <LastName>Mirzaaghayan</LastName>
                <affiliation locale="en_US">Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Leili</FirstName>
                <LastName>Koochakzade</LastName>
                <affiliation locale="en_US">3Division of Pediatric Oncology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Aalie</FirstName>
                <LastName>Safari</LastName>
                <affiliation locale="en_US">3Division of Pediatric Oncology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Mohammad Taghi</FirstName>
                <LastName>Majnoon</LastName>
                <affiliation locale="en_US">1Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Ali-Asghar</FirstName>
                <LastName>Zeinaloo</LastName>
                <affiliation locale="en_US">1Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Chehreh</FirstName>
                <LastName>Mahdavi</LastName>
                <affiliation locale="en_US">1Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Azin</FirstName>
                <LastName>Ghamari</LastName>
                <affiliation locale="en_US">2Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Ehsan</FirstName>
                <LastName>Aghaei Moghadam</LastName>
                <affiliation locale="en_US">Division of Pediatric Cardiology, Children’s Medical Center, No 62, Dr. Gharib St, Tehran, Iran, Division of Pediatric Cardiology, Children’s Medical Center, No 62, Dr. Gharib St, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Armen</FirstName>
                <LastName>Kocharian</LastName>
                <affiliation locale="en_US">1Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Farzad</FirstName>
                <LastName>Kompani</LastName>
                <affiliation locale="en_US">of Pediatric Oncology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Maryam</FirstName>
                <LastName>Nikoufar</LastName>
                <affiliation locale="en_US">1Division of Pediatric Cardiology, Children’s Medical Center Tehran University of Medical Sciences, Tehran, Iran</affiliation>
            </Author>
        </AuthorList>
        <ArticleType>Research Article</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>4</Month>
                <Day>16</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>31</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Background : Despite high effectiveness of Anthracycline as a potent antineoplastic agent, its-related cardiothoxicity is the most notorious complication. The purpose of our study was to assess the value of using different methods (LVEF, E, E’, A and Tei index versus global longitudinal strain) for detection of early cardiac changes by measuring them before and one month after the Anthracycline administration in a cross-sectional cohort study. Methods : This cross-sectional study was performed on 22 new diagnosed cancer patients aged 18 years or younger who referred to the children Medical center in Tehran in 2016 as the cases and also 22 age-matched healthy children who referred to the center because of any non-cardiac reasons as the control. All participants were assessed to determine the left ventricular functional indices before and also one month after starting the therapeutic regimen containing Anthracycline. Results : Among all parameters assessed by echocardiography, only the mitral annular peak systolic velocity (Sm) significantly reduced after administrating Anthracycline compared to before that. Data for patients and the control group showed no statistical significant differences before the therapy as well. Conclusions : Our findings show that evaluating Sm is most useful for early detection of cardiac changes. This may be due to our limitation of small cohort studies and also the short interval after the drug administration; although this was related to the main goal of our study.</abstract>
        <web_url>http://comprped.com/en/articles/59701.html</web_url>
        <pdf_url>https://cdn.neoscriber.org/cdn/dl/fce9bf70-b1c0-11e8-acb8-77d9dfe64ac5</pdf_url>
    </Article>
</Articles>
